BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 26, 2010
View Archived Issues
SCH-527123 shows potential in severe neutrophilic asthma
Read More
ROSE-010 acts via exendin receptor and is linked to treatment compliance in IBS
Read More
Snapshots: Phase III trials of meningococcal vaccine MenACWY-TT
Read More
sCD83 prevents renal allograft rejection in kidney transplantation models
Read More
ONO-5334 shows promise in postmenopausal osteoporosis
Read More
Tolcapone beneficial in patients with psychosis
Read More
EG-Mirotin restores blood flow in oxygen-induced retinopathy model
Read More
Shire updates progress of first quarter 2010
Read More
AstraZeneca describes novel inhibitors of Abeta production
Read More
Deciphera claims novel protein kinase inhibitors
Read More
New gamma-secretase modulators disclosed by Roche
Read More
Genentech identifies new Janus kinase inhibitors
Read More
NGR-hTNF cleared to enter phase III mesothelioma trial in U.S.
Read More
Pharming submits Rhucin MAA response to EMA
Read More
EpiCept launches Ceplene in Germany for acute myeloid leukemia
Read More
FDA accepts Clinical Data's vilazodone NDA for major depressive disorder
Read More
Can-Fite's phase II CF-101 trial in glaucoma approved in Israel
Read More
Abbott acquires Piramal's Healthcare Solutions business in India
Read More
FDA grants orphan drug status to RG-2833 in Friedreich's ataxia
Read More
Pro-Pharmaceuticals plans phase III trial of Davanat
Read More
Salix launches Xifaxax 550-mg tablets for hepatic encephalopathy
Read More
American Life Science receives ADDF grant to enable phase I AB-007 trials
Read More
Neuralstem progresses phase I trial of spinal cord stem cells in ALS
Read More
Enrollment initiated in phase III daclizumab trial in RRMS
Read More
Boehringer Ingelheim selects Nanobody lead to develop in AD
Read More
DMC recommends continued analysis of phase III deforolimus data
Read More